Navigation Links
Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorectal Cancer
Date:9/24/2009

THOUSAND OAKS, Calif., Sept. 24 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced detailed results from the Phase 3 '203' trial evaluating Vectibix(R) (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as the first-line treatment of metastatic colorectal cancer (mCRC). In this trial, Vectibix significantly improved median progression-free survival (PFS) by 1.6 months (9.6 versus 8.0 months for patients treated with FOLFOX alone, (hazard ratio 0.80; p=0.02)) in patients with KRAS wild-type mCRC (primary endpoint). The results were presented at the 2009 ECCO 15 - ESMO 34 European Multidisciplinary Congress in Berlin, Germany (Abstract Number 10LBA).

Further, the addition of Vectibix to chemotherapy also improved response rate in the KRAS wild-type patient population as measured by blinded central review (55 percent versus 48 percent in the FOLFOX only arm).

"I am very pleased with the outcome of this high quality trial which demonstrated that Vectibix improved progression-free survival and appeared to be well tolerated as a first-line metastatic colorectal cancer treatment in a selected patient population," said Jean-Yves Douillard, director Clinical and Translational Research, Medical Oncology Branch, Centre R Gauducheau, France and the study's principal investigator. "This is the first prospective Phase 3 data to demonstrate the importance of KRAS mutation as a predictive biomarker for Vectibix treatment in the first-line setting, providing definitive support for the use of the KRAS biomarker for selection of patients eligible for anti-EGFR therapy."

Importantly, in patients with tumors harboring activating KRAS mutations, PFS was significantly inferior in the V
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in Second-Line Metastatic Colorectal Cancer
2. Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer
3. Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer
4. In Vitro Study of Adamas Pharmaceuticals Triple Combination Antiviral Drug Therapy Shows Activity Against Drug-Resistant Influenza Viruses
5. Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
6. Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
7. Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)
8. Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
9. Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
10. Pixantrone in Combination with Chemotherapy Regimens Produces Overall Response Rates of 58-74% with Complete Remission Rates of 37-57% in Relapsed/Refractory Aggressive or Indolent NHL
11. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 Medical science liaisons (MSLs) play ... opinion leaders (KOLs) who can provide essential insights ... nature of the MSL function, the changing regulatory ... landscape for creating and maintaining KOL and physician ... oversight responsibility for the MSL function is increasingly ...
(Date:9/19/2014)... "Copay coupons," a drug manufacturer ... drugs among patients with prescription drug coverage, may now be ... report  from the Department of Health and ... anti-kickback laws prohibit suppliers from offering side-payments to ... the federal government. The report ...
(Date:9/19/2014)... 2014 /PRNewswire-iReach/ -- "United States General ... key market data on the United ... report provides value, in millions of ... within market categories – Bronchoscopes, Laryngoscopes, ... Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, ...
Breaking Medicine Technology:Role of Medical Science Liaisons Shifting in Healthcare Industry 2PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D 2United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 2United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 3United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 4United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 5
... 2012  Verenium Corporation (Nasdaq: VRNM ), a leading ... high-performance enzymes, today announced that Janet Roemer, Executive Vice President ... Bank Clean Tech, Utilities and Power Conference as part of ... 2:15 p.m. ET on Monday, May 14, 2012 in New ...
... Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one ... of China, today announced that it will host its earnings ... 9, 2012 at 8:00 a.m. EDT (New York), which is ... Hosting the call will be Mr. Colin Zhao, President ...
Cached Medicine Technology:Verenium To Present At The Deutsche Bank 2012 Clean Tech, Utilities & Power Conference 2China Biologic Products to Host Earnings Conference Call on May 9, 2012 at 8:00 a.m. EDT (NY) 2
(Date:9/22/2014)... September 22, 2014 Thousand Oaks ... special offer for Invisalign. Invisalign is a type of ... bite problems. Typical pricing can vary based on the ... of aligners that are needed. During this promotion, Dr. ... , About a fifth of the adult population has ...
(Date:9/22/2014)... Steven Reinberg HealthDay Reporter ... that bacterial pneumonia can raise your risk of heart problems, ... and kill heart cells, increasing the chances of heart failure, ... report. In mice, monkeys and human heart tissue, researchers ... and they tried a vaccine that might one day prevent ...
(Date:9/22/2014)... 2014 Caliper, an internationally recognized talent ... honored once again with the When Work Works Award ... has allowed Caliper to increase business and employee success. ... to meet both work and family commitments effectively. As ... at an all-time high. , “At Caliper, our ...
(Date:9/22/2014)... Tristar Products, Inc. is celebrating the 100th ... as the 'Godfather of Fitness,' with the release of ... 24th at the TriBeCa Film Center® in New York ... the man whose mission was to show the world ... name of the film is derived from one of ...
(Date:9/22/2014)... LifeAnt.com, a life insurance provider based ... article to its website that may cause millions of ... dismayed. Titled “Coffee Drinkers Beware! You’re Paying More for ... average, coffee fans tend to pay higher prices for ... enjoy the tasty beverage. , In fact, as Thomas ...
Breaking Medicine News(10 mins):Health News:Thousand Oaks Cosmetic Dentist, Sharon Shamoiel DDS, Is Now Offering a Special on Invisalign 2Health News:Scientists Spot How Bacterial Pneumonia Damages the Heart 2Health News:Scientists Spot How Bacterial Pneumonia Damages the Heart 3Health News:Caliper Recognized Second Year in a Row For Exemplary Workplace Practices 2Health News:Caliper Recognized Second Year in a Row For Exemplary Workplace Practices 3Health News:Tristar Products Premieres The Jack LaLanne Documentary at TriBeCa Film Center in New York City 2Health News:Tristar Products Premieres The Jack LaLanne Documentary at TriBeCa Film Center in New York City 3Health News:Coffee Drinkers Are Charged More For Life Insurance, Reports LifeAnt.com 2
... behind gender difference isn,t clear, researchers say , , ... 2 diabetes have a 26 percent increased risk of ... findings suggest. , The overall incidence of atrial fibrillation ... while the rate for people without the metabolic condition ...
... developmental origin of specialized skin cells involved in touch sensation. ... of the Journal of Cell Biology (online September ... cells that reside in the vertebrate epidermis, passing mechanical stimuli ... in the paws and around the whiskers but, because they ...
... of Public Health and The Boston Globe finds 59% of Massachusetts ... was enacted in 2006, support it. A little more than one ... level of public support for the law has declined somewhat in ... 2008 to 59% in the current poll. The current number is ...
... the same drugs that have buoyed long-term survival rates ... joint pain so severe that many patients discontinue these ... research, however, has uncovered patterns that may help clinicians ... sooner in order to increase their chances of sticking ...
... New Text ... ... (Axiom), one of the nation,s leaders in clinical research support and integrated healthcare marketing, ... outreach is the future of patient recruitment , due to the growth and convenience ...
... survey shows , MONDAY, Sept. 28 (HealthDay News) -- Parents ... growth charts widely used in pediatrician,s offices, but many parents ... new survey shows. , About 85 percent of parents could ... correctly identify that the point corresponded to the child,s age, ...
Cached Medicine News:Health News:Irregular Heartbeat Risk Higher in Women With Type 2 Diabetes 2Health News:Irregular Heartbeat Risk Higher in Women With Type 2 Diabetes 3Health News:59 percent support Massachusetts' Landmark 2006 health reform law 2Health News:59 percent support Massachusetts' Landmark 2006 health reform law 3Health News:Penn studies point to strategies for reducing painful breast cancer drug side effects 2Health News:Penn studies point to strategies for reducing painful breast cancer drug side effects 3Health News:Axiom Accelerated Patient Recruitment Rolls Out 2Health News:Children's Growth Charts Don't Measure Up With Parents 2Health News:Children's Growth Charts Don't Measure Up With Parents 3
... to 17 parameters from just 95 ... blood gases, as well as any ... metabolite parameters. Unique technology reduces to ... substances have on the accuracy of ...
... a sophisticated whole blood analysis system that ... also satisfying the stringent requirements of the ... contains all of the components of a ... the sampling unit, all of the sensors ...
... The Rapidlab 800 System is a ... key critical care whole blood parameters in ... modular design allows the basic blood gas ... to include electrolytes, metabolites and CO-oximetry in ...
This compact, easy-to-operate analyzer delivers basic blood gas, ISEs with direct measured total hemoglobin and saturated oxygen. Use it as a cost effective backup for the central lab or for remote p...
Medicine Products: